Correction: A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study).
BMC Med
; 20(1): 478, 2022 Dec 08.
Article
in En
| MEDLINE
| ID: mdl-36482439
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
Language:
En
Journal:
BMC Med
Journal subject:
MEDICINA
Year:
2022
Type:
Article
Affiliation country:
Japan